Incomplete Response in Late Life Depression: Getting to Remission

Trial Profile

Incomplete Response in Late Life Depression: Getting to Remission

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Jun 2018

At a glance

  • Drugs Aripiprazole (Primary) ; Venlafaxine (Primary)
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Acronyms IRL Grey; IRLGREY
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 19 Jun 2018 Results assessing clinical predictors of extrapyramidal symptoms associated With Aripiprazole augmentation, published in the Journal of Clinical Psychiatry
    • 03 Apr 2018 Results (n=468) assessing executive function (EF) is associated with nonremission and noncompletion of antidepressant pharmacotherapy in older adults with depression, were published in the Journal of Clinical Psychiatry.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top